- Abstract
- Keywords
- Introduction
- Chemistry of BD
- Antineoplastic effects of BD in human malignancies
- Anti-metastatic effects of BD
- Potential anti-inflammatory effects of BD
- Pharmacokinetics, toxicity and metabolism
- Clinical application of BD
- Conclusion and future directions
- Abbreviations
- Declarations
- References
-
Citing Article List
The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Promising immunotherapeutic approaches for primary effusion lymphoma”.No. Publication Date Citing Article 1 2025 Victor A. Losay, Blossom Damania. Unraveling the Kaposi Sarcoma-Associated Herpesvirus (KSHV) Lifecycle: An Overview of Latency, Lytic Replication, and KSHV-Associated Diseases, Viruses. 2025; 17: 177. https://doi.org/10.3390/v17020177 2 2025 Lu Dai, Amrita Choudhary, Jiaojiao Fan, Lu Huang, Zhen Lin, Zhiqiang Qin. Identification of RP‐54745, an IL‐1 Inhibitor Displaying Anticancer Activities for KSHV‐Related Primary Effusion Lymphoma, Journal of Medical Virology. 2025; 97: e70200. https://doi.org/10.1002/jmv.70200 3 2024 Esther Niilonga Kalambi-Matengu, Elizabeth Botsile. 2024; https://doi.org/10.5772/intechopen.115534 -
